CONTROLLED RELEASE ORAL DOSAGE FORMULATIONS COMPRISING APLINDORE, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, USES THEREOF AND SETS OF CONTROLLED RELEASE DOSAGE FORMS
The present invention provides controlled release dosage formulations of compounds having the Formula (I) or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.Linvention concerne des formulations posologiques à libération lente des composés possédant la formule (I) ou de leurs sels pharmaceutiquement acceptables et notamment de laplindore. Les formes posologiques sont utiles, entre autres, pour réduire les effets secondaires de ladministration de ces composés.
